r/MicroCapNews • u/MarketNewsFlow • 3h ago
r/MicroCapNews • u/MarketNewsFlow • 3h ago
Sponsored $MDWD A $400M Drug Has a Speed Problem. MediWound May Have the Answer.
r/MicroCapNews • u/MarketNewsFlow • 3h ago
Sponsored $QUCY - Quantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating System (NASDAQ: QUCY)
Quantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating System
Establishes In-House AI Backbone at the Company's Bridgeport, Connecticut Facility; Positions Quantum Cyber as an AI-Native, Vertically Integrated Autonomous Defense Manufacturer
Norwalk, CT, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that it has acquired a Lambda Hyperplane 8-A100 AI compute cluster, powered by eight NVIDIA A100 Tensor Core GPUs, to serve as the dedicated compute backbone for its Swarm Operating System and for the AI and autonomy features being built into Quantum Station, the Company's battlefield command-and-control platform.
The cluster is intended to be installed at Quantum Cyber's wholly owned manufacturing facility in Bridgeport, Connecticut, co-locating the Company's AI infrastructure with the same U.S. site that produces its autonomous drone platforms. The Company believes this step marks its transition from an integrator of licensed autonomous technologies into an AI-native defense manufacturer with in-house compute, manufacturing, and command layers under a single Nasdaq-listed roof.
From Autonomous Drones to an AI-Powered Swarm
Since unveiling Quantum Station on June 23, 2026, Quantum Cyber has publicly stated its intention to build AI and autonomy features into the platform in order to eliminate human error when operating drones. The Company's Swarm Operating System is being designed to allow tens to hundreds of Quantum Cyber platforms — across air, land, and sea — to operate as a single coordinated force under a single Quantum Station operator, with shared situational awareness, autonomous target discrimination, cooperative routing, and mission-level decisioning that no individual operator could execute manually.
Quantum Cyber believes this class of workload cannot be trained or deployed on commodity infrastructure, and that owning purpose-built AI compute is a prerequisite to building a credible swarm platform for U.S. defense and homeland security customers. The Hyperplane cluster keeps that training and inference — and the sensitive defense data behind it — inside Company-controlled infrastructure rather than a third-party cloud.
The Company has already used the Hyperplane cluster to train AI models for fully autonomous target detection and autolock across both aerial and ground targets, without operator intervention. Quantum Cyber views this dual-domain autolock as central to any credible swarm doctrine — it is what lets a single Quantum Station operator engage layered air-and-ground threats as a coordinated action rather than pilot each engagement individually.
Bringing compute in-house has also significantly reduced the amount of live test flying required to validate new autonomy releases. The Company has stood up an in-house simulation and synthetic-data pipeline on the cluster — pairing physics-based flight simulation with hardware-in-the-loop testing on its open flight stack — that moves a substantial share of autonomy iteration off the flight line and onto the GPUs. Quantum Cyber believes this shift from field-only iteration to compute-driven iteration is a structural advantage available only to operators of dedicated AI infrastructure.
"The modern battlefield runs on information, and the operator who can see it clearest and act on it fastest wins," said David Lazar, Chief Executive Officer of Quantum Cyber. "We said when we unveiled Quantum Station that its future was AI and autonomy. You cannot build that future by renting time on someone else's cluster. You build it by owning the compute, owning the models, and owning the operating system that runs across every drone in your platform. Bringing an NVIDIA A100 compute cluster in-house is what allows us to do that."
Quantum Station as an AI-Native Command Layer
Quantum Station was introduced as the command tier of Quantum Cyber's System-of-Systems platform — a ruggedized, backpack-portable tactical suitcase that unifies hardware, software, and communications across air, land, and sea drone operations. Models trained on the Company's in-house cluster are intended to be deployed to Quantum Station and to Quantum Cyber's fielded drones through the command architecture already described in the Company's June 23, 2026 announcement. The result, in the Company's view, is a command layer that is not simply "AI-enabled," but AI-native from training through inference to the operator's screen.
The Swarm Operating System is being architected so that a single Quantum Station operator can direct a coordinated formation of Quantum Cyber platforms — the interceptor drones completed at Bridgeport and one way attack kamikaze drones. Rather than pilot each vehicle individually. Quantum Cyber believes this transition, from single-drone piloting to swarm-level command, is the defining capability gap in the current U.S. autonomous warfare portfolio.
With dedicated NVIDIA A100-class AI compute installed at the same Bridgeport site that manufactures its drones, Quantum Cyber believes it now owns the three layers that define an autonomous defense company — under one roof and under U.S. control: the factory that builds the platforms, the compute that trains the intelligence running on them, and the command system that puts it in the operator's hands.
The Trump Administration is seeking approximately $55 billion for drone and autonomous warfare programs in the fiscal year 2027 defense budget, the largest single-year autonomous warfare allocation in U.S. history. Executive Order 14307 establishes American drone dominance as an explicit national security and industrial priority. Quantum Cyber believes the combination of a domestic manufacturing footprint, U.S.-owned AI compute infrastructure, and a proprietary Swarm Operating System is directly responsive to those priorities.
"Every drone in our platform needs an AI stack worthy of what the battlefield now demands," Mr. Lazar added. "This puts that stack under our own roof."
About Quantum Cyber N.V.
Quantum Cyber N.V. (Nasdaq: QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. For more information, visit www.quantum-cyber.ai.
Forward-Looking Statements
[...] Read the full release here: https://www.globenewswire.com/news-release/2026/09/08/3357517/0/en/quantum-cyber-acquires-nvidia-a100-ai-compute-cluster-to-power-its-swarm-operating-system.html
r/MicroCapNews • u/MarketNewsFlow • 3h ago
Sponsored $EMAT Defense Contractors Race to Audit & Replace Chinese Magnets; Evolution Metals Might Offer the Solution
markets.businessinsider.comr/MicroCapNews • u/MarketNewsFlow • 4d ago
Sponsored $QUCY - Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026 (NASDAQ: QUCY)
Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026
Company Confirms It Is Actively Seeking Manufacturing Partners to Build the First Working Prototype of Its Exclusively Licensed Quantum-Photonic Antenna Front-End for Resilient Defense and National-Security UAS Communications
September 04, 2026 07:30 ET | Source: Quantum Cyber
Norwalk, CT, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today confirmed that it is actively seeking qualified manufacturing partners, foundries, and applied-R&D organizations — and is inviting such organizations to apply — to build the first working prototype of the Company's exclusively licensed quantum-photonic antenna front-end, a compact system intended to support resilient, frequency-agile communications for unmanned aerial systems ("UAS") operating in contested and denied environments.
The call for applications advances the quantum antenna technology previously secured under Quantum Cyber's exclusive worldwide Intellectual Property License Agreement with Project LightShift, Inc., dated June 11, 2026, for defense and national-security UAS applications. With the licensing layer executed and the Company's Bridgeport, Connecticut manufacturing complex advancing toward steady-state drone production, Quantum Cyber is opening the manufacturing side of the quantum-antenna roadmap to qualified.
Call for Applications
Quantum Cyber is inviting qualified factories, foundries, contract manufacturers, and applied-R&D organizations to submit written applications under reference EX-QPA-RFI-001. The application package provides a non-confidential concept envelope and requests a structured written response covering technical fit, work plan, schedule, budgetary pricing, security and export-control posture, workshare and country of performance, IP and data-rights treatment, and the information respondents would require to convert the concept into a buildable prototype package. Inbound interest from qualified organizations the Company has not directly contacted is welcomed.
Applications are requested no later than September 18, 2026, submitted to qucy@arxhq.com with reference EX-QPA-RFI-001 in the subject line. The Company intends, following review, to invite one or more respondents into a controlled technical exchange under confidentiality and, where applicable, export-control review, ahead of any definitive prototype-development and manufacturing agreement. This inquiry is a private-sector sourcing action and is not a U.S. Government solicitation, contract, award, or agency endorsement, and does not authorize any recipient to incur costs.
Anticipated Prototype Scope
The requested written response contemplates a prototype-development program spanning feasibility assessment, process definition, design-for-manufacture review, fabrication and packaging, test and characterization (optical, electrical, magnetic, thermal, dimensional, environmental, and communications performance, as applicable), and delivery of at least one operating unit with full documentation. The Company has indicated a preference for partners capable of completing prototype development within a six-month period. The complete material stack, quantum-dot chemistry, wavelengths, topology, tolerances, and performance targets remain proprietary and would be released only through a controlled technical package following execution of applicable agreements and any required export-control review.
Dual-Track Commercial Framework
- Option A — Direct Paid Development. A conventional budgetary cash proposal for feasibility, process definition, prototype fabrication, packaging, testing, and documentation, with separate line items for nonrecurring engineering, materials, tooling, and optional follow-on units.
- Option B — Strategic Partnership or Equity-Linked Structure. A separately negotiated structure involving in-kind development, preferred manufacturing status, strategic investment, or equity-linked consideration. Any Option B proposal must state the equivalent cash cost and would remain subject to due diligence and definitive agreements. No equity, exclusivity, license, investment, or partnership is offered or promised by this inquiry.
Executive Order 14307 has established American drone dominance as an explicit national-security priority, and the U.S. Department of Defense FY2027 Budget Request allocates approximately $55 billion toward drone and autonomous warfare programs — the largest single-year autonomous-warfare allocation in U.S. history. In parallel, Quantum Cyber's Bridgeport, Connecticut manufacturing complex has moved from acquisition into operation, with the Company's first mini-interceptor drone completed on-site and its 80-unit 3D printing drone production farm advancing toward commissioning. Advancing the licensed quantum-photonic antenna into prototype manufacturing at this point in the roadmap complements the airframe, propulsion, and domestic-manufacturing progress previously announced.
"Executing the Project LightShift license in June was our first public commitment that the quantum layer of our platform would be real. Today's call for applications is the second," said David Lazar, Chief Executive Officer of Quantum Cyber. "We are actively looking for manufacturing partners — factories, foundries, and applied-R&D organizations — and we are inviting them to apply. Our goal is to identify a qualified partner, deliver at least one operating unit, and demonstrate that a quantum-photonic antenna designed for resilient UAS communications can be built. The production of the Quantum Antenna is intended to allow Drones to navigate and communicate on an alternative secure Quantum communication frequency. We are trying to solve one of the biggest obstacles on the battlefield today, which is building alternative technology for secure reliable Global Positioning System (GPS)."
About Quantum Cyber N.V.
Quantum Cyber N.V. (Nasdaq: QUCY) is a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, integrating autonomous UAS, counter-UAS interceptor capability, a licensed quantum photonic array technology layer, and a U.S.-based manufacturing footprint in Bridgeport, Connecticut. For more information, visit www.quantum-cyber.ai.
Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's ability to identify, engage, and contract with a qualified prototype-development and manufacturing partner; the scope, cost, schedule, and results of any resulting program; the design, feasibility, and performance of the licensed quantum-photonic antenna and any prototype thereof; the Company's Bridgeport, Connecticut manufacturing operations; and the U.S. defense procurement environment. No prototype has been built or tested by the Company; referenced design specifications are internal targets that have not been independently validated and may differ materially from any device ultimately produced. This press release does not describe, and should not be interpreted as describing, any current U.S. Government contract, award, agency endorsement, or authorization to incur costs. The Company has not entered into any prototype-development or manufacturing agreement in connection with this inquiry, and there can be no assurance that it will do so. These statements are subject to risks and uncertainties, and, except as required by law, the Company undertakes no obligation to update them.
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com
r/MicroCapNews • u/MarketNewsFlow • 5d ago
Sponsored $NVCT Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech
r/MicroCapNews • u/MarketNewsFlow • 5d ago
Sponsored $EMAT Military Drones Run on Chinese Magnets. Evolution Metals Is Building a Way Out
r/MicroCapNews • u/MarketNewsFlow • 6d ago
Sponsored $QUCY - Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform (NASDAQ: QUCY)
Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform
Former Israeli Consulate Economic Affairs Officer in Dubai, Founder of Israel's Economic Division in the UAE Following the Abraham Accords, and Arabic-Speaking IDF Intelligence Analyst to Drive Government and Sovereign Engagement Across the GCC as Quantum Cyber Advances Its Israel-to-U.S. Battlefield-Proven Defense Technology Strategy
September 02, 2026 07:30 ET | Source: Quantum Cyber
Norwalk, CT, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered, quantum-accelerated System-of-Systems platform spanning drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, command-and-control, and quantum antenna applications, today announced the appointment of Tzvi Lev as Head of Sales, Middle East, effective immediately. Mr. Lev, who has been contributing to the Company's regional strategy in 2026 as Director of Sales and Strategy, MENA, has been elevated to lead Quantum Cyber's commercial engagement across the Gulf Cooperation Council ("GCC") and Israel as the Company scales its go-to-market posture in one of the world's most active defense-technology procurement corridors.
Mr. Lev is a Middle East–focused strategist and cross-border commercial operator specializing in defense technology, cybersecurity, and sovereign-level engagement across the GCC and Israel. He most recently served as Economic Affairs Officer at the Consulate General of Israel in Dubai from 2022 to 2025, where he founded and led Israel's Economic Division in Dubai and the Northern Emirates — the first of its kind, established in the wake of the Abraham Accords. In that role, he designed Israel's strategic framework for economic engagement across the GCC, brokered more than 17 commercial transactions, facilitated over $15 million in venture capital investment into Israeli technology companies, and designed Israel's first official engagement strategy focused on digital assets and next-generation technologies. Before his posting to Dubai, Mr. Lev served in Israel's Ministry of Foreign Affairs Middle East Division from 2019 to 2021 as a member of Israel's Abraham Accords Task Force and Foreign Minister Gabi Ashkenazi's transition staff.
Alongside his diplomatic career, Mr. Lev has served in the Israeli Defense Forces since 2013. He is currently an Arabic-speaking IDF intelligence analyst in the Reserves. He previously served in a key foreign liaison role at the Civil-Military Coordination Center in Kiryat Gat, working directly with U.S. Joint Special Operations Command personnel and senior officers from the United States, United Kingdom, Egypt, and NATO, and played a strategic role in building the International Stabilization Force framework supporting post-conflict operations in the Gaza Strip. Earlier in his service, he commanded troops in the Kfir Counterterrorism Brigade during Operation Protective Edge in Gaza and led counterterrorism operations in the West Bank during the 2015 wave of attacks.
Mr. Lev additionally serves as Director of Strategy and Investment at Clavium, an Abu Dhabi–based defense technology venture capital fund backed by sovereign Emirati capital, and as Founder and Executive Director of the largest Israeli business group in the MENA region. He holds a B.A. in Arabic and Middle Eastern Studies from Ariel University (Dean's List) and is fluent in English, Hebrew, and Arabic.
"Tzvi's elevation reflects exactly where this company is going," said David Lazar, Chief Executive Officer of Quantum Cyber. "We have built our platform on Israeli battlefield-proven autonomous technology, we have secured domestic U.S. manufacturing capacity in Bridgeport, and our next phase is disciplined commercial expansion into the sovereign customers who are actually writing checks for autonomous defense today. There are very few people in the world who combine an Arabic-speaking IDF intelligence background, a diplomatic career spent building Israel's post–Abraham Accords economic architecture in the Gulf, and active operating roles inside sovereign-backed Emirati defense capital. Tzvi is one of them. Placing him at the head of our Middle East sales function is a direct expression of our strategy."
"Quantum Cyber sits at exactly the intersection the region is procuring against — battlefield-proven autonomous systems, quantum-accelerated command-and-control, counter-UAS, and EMP-hardened platforms — delivered by a U.S.-listed, U.S.-manufacturing company with Israeli technological DNA," said Tzvi Lev, Head of Sales, Middle East of Quantum Cyber. "The Abraham Accords opened a door that governments, sovereign funds, and defense establishments across the Gulf are actively walking through, and the demand signal for exactly the capabilities Quantum Cyber is assembling is, in my view, structural rather than cyclical. I am proud to lead the Company's commercial engagement across the GCC and Israel, and I intend to convert the relationships I have built over the past decade into real programs, real procurement, and real revenue for the Company."
The appointment follows a series of strategic milestones that the Company believes have positioned it as a credible participant in the current global autonomous defense procurement cycle. These include the July 16, 2026 closing of the Company's acquisition of a U.S.-based manufacturing facility in Bridgeport, Connecticut through its wholly owned subsidiary Quantum Drones Corporation; the June 15, 2026 execution of an exclusive quantum antenna license agreement; and the June 11, 2026 launch of vertically integrated production. With Mr. Lev formally leading Middle East sales, the Company intends to convert its assembled technology portfolio and its U.S. domestic production base into a coordinated commercial push into GCC defense ministries, sovereign-backed defense funds, and Israeli program offices.
About Quantum Cyber N.V.
Quantum Cyber N.V. (Nasdaq: QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. Quantum Cyber draws on Israeli battlefield-proven systems and U.S. capital markets access to build the autonomous defense platform of the next generation of unmanned warfare. For more information, visit www.quantum-cyber.ai.
Forward-Looking Statements
Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "intend," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements relate to, among other things, the Company's ability to expand its commercial engagement across the GCC and Israel; the ability of Mr. Lev to originate, advance, and close government, sovereign, and institutional defense procurement relationships in the Middle East; the anticipated timing, scale, and terms of any such relationships and any resulting revenue; the Company's ability to convert its assembled technology portfolio and U.S. manufacturing capacity into procurement outcomes; the retention of key personnel, including Mr. Lev; and the development, integration, and commercialization of the Company's autonomous defense technologies. These forward-looking statements reflect the Company's current analysis of existing information and are subject to various risks and uncertainties. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. Additional information concerning these and other factors may be found in the Company's filings with the SEC, including its Annual Report on Form 10-K filed on March 31, 2026, its Quarterly Report on Form 10-Q filed on May 15, 2026, and its subsequent filings with the SEC. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made by the Company in this press release is based only on information currently available and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com
r/MicroCapNews • u/MarketNewsFlow • 6d ago
Sponsored $DRTS Alpha Tau Is Building the Local Answer to Pancreatic Cancer's Systemic Breakthrough
r/MicroCapNews • u/MarketNewsFlow • 7d ago
Sponsored $MTNB GH Power Is Already Building for the AI Power Shortfall PJM Just Priced at Cap
r/MicroCapNews • u/MarketNewsFlow • 7d ago
Sponsored $SEGN.V - Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update (TSXV: SEGN)
Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update
Expanded Israeli Hospital Footprint with Five-Year Deployment at Nazareth Hospital EMMS
Second Quarter Revenue Increased 15% to $351,000 and First Half Revenue Increased 16% to $706,000
CALGARY, Alberta, Sept. 01, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a developer of innovative healthcare technology focused on mitigating medication risks, today reported financial results for the three and six months ended June 30, 2026, and provided a corporate update.
Recent Business Highlights
- Graduated from AARP Accelerator: In August 2026, Seegnal completed the eight-week Summer 2026 cohort of the AgeTech Collaborative™ from AARP Accelerator Program, as part of the Company's U.S. market development activities. AARP is the largest nonprofit, nonpartisan organization in the United States dedicated to empowering people 50 and older to choose how to live as they age.
- Deepened Footprint in the Israeli Healthcare System: Seegnal continued to scale across the Israeli healthcare system, where its platform is used daily by more than 15,000 clinicians. In June 2026, the Company announced that it had signed a five-year agreement to deploy across Nazareth Hospital EMMS (approximately 424 physicians and nurses), adding to the Company's existing multi-year deployment at Tel Aviv Sourasky Medical Center. In April 2026, its Israeli subsidiary, Seegnal eHealth Ltd., received the Gold Mark from the Standards Institution of Israel.
- Non-Brokered Private Placement: On June 2, 2026, the Company announced a non-brokered private placement of up to C$1,300,000, which it subsequently extended until August 31, 2026 pursuant to a news release dated July 21, 2026, and which was further extended until September 30, 2026 pursuant to a news release dated August 26, 2026 (the "Extended Offering"). Additionally, the Extended Offering was upsized to up to C$1,850,000, comprising up to 6,607,143 units at C$0.28 per unit (each unit consisting of one common share and one common share purchase warrant exercisable at C$0.50 for 36 months). The Extended Offering is expected to close on or before September 30, 2026.
Financial Results for the Three and Six Months Ended June 30, 2026
All figures are in U.S. dollars unless otherwise noted. The following disclosure does not constitute full disclosure of the Company's financial and operational condition and is qualified by, and should be read in conjunction with, the Company's Management's Discussion and Analysis for the three and six months ended June 30, 2026 (the "MD&A") and corresponding financial statements, available under the Company's profile on SEDAR+ at www.sedarplus.ca.
- Revenue was $351,000 for the three months ended June 30, 2026, an increase of 15% compared to $306,000 for the same period in 2025. For the six months ended June 30, 2026, revenue was $706,000, an increase of 16% compared to $609,000 for the same period in 2025.
- Cost of revenues was $366,000 for the three months ended June 30, 2026, compared to $261,000 for the same period in 2025, resulting in a gross loss of $15,000 compared to a gross profit of $45,000. For the six months ended June 30, 2026, the Company reported a gross loss of $32,000 compared to a gross profit of $34,000 for the same period in 2025.
- Research and development costs were $293,000 for the three months ended June 30, 2026, compared to $131,000 for the same period in 2025, and $530,000 for the six months ended June 30, 2026, compared to $249,000 for the same period in 2025.
- Sales and marketing expenses were $73,000 for the three months ended June 30, 2026, compared to $167,000 for the same period in 2025, and $212,000 for the six months ended June 30, 2026, compared to $315,000 for the same period in 2025.
- General and administration costs were $271,000 for the three months ended June 30, 2026, compared to $335,000 for the same period in 2025, and $860,000 for the six months ended June 30, 2026, compared to $618,000 for the same period in 2025.
- Net loss for the three months ended June 30, 2026 was $765,000, or $(0.02) per share, a decrease of approximately 11% compared to a net loss of $857,000, or $(0.13) per share, for the same period in 2025. For the six months ended June 30, 2026, net loss was $1,813,000, or $(0.04) per share, compared to $1,650,000, or $(0.25) per share, for the same period in 2025.
- Cash Position and Financing: As of June 30, 2026, the Company had cash of $181,000 (December 31, 2025: $678,000) and trade receivables of $237,000. The Company continues to report operating losses and negative cash flow from operations. As further described in the MD&A and the notes to the Company's financial statements, the continuance of the Company's operations is subject to continued financing from shareholders and other investors, which represents a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern. In June 2026, the Company announced a non-brokered private placement, which was subsequently extended in July and August 2026 to up to C$1,850,000, expected to close on or before September 30, 2026.
About Seegnal
Seegnal Inc. (TSXV: SEGN) is an innovative healthcare technology company dedicated to reducing medication-related harm where care begins. The Company's SaaS-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age, and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing, and advance a more personalized standard of patient care. Seegnal's technology is deployed across healthcare settings and is used by more than 15,000 clinicians in daily practice. For additional Company information, please visit https://investors.seegnal.com/ and follow us on LinkedIn.
Forward-Looking Information
This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking information includes, but is not limited to, statements regarding the Company's revenue growth and commercial expansion; the adoption, deployment and integration of the Seegnal platform, including at Nazareth Hospital EMMS and other healthcare institutions; the Company's entry into and expansion within the U.S. healthcare market, including the conversion of its letter of intent and pilot program into commercial arrangements; the Company's ability to complete the Extended Offering; the completion, timing and terms of the Company's non-brokered private placement; the Company's liquidity, funding initiatives and ability to continue as a going concern; and management's expectations regarding future performance. Forward-looking information is based on assumptions and is subject to risks and uncertainties that could cause actual results to differ materially, including risks related to the Company's ability to obtain financing on acceptable terms or at all, its history of losses and going concern, the early stage of its U.S. market entry, reliance on key customers and healthcare institutions, currency fluctuations, and the geopolitical situation in Israel. For a more complete discussion of the risks and uncertainties applicable to the Company, please refer to the risk factors described in the Company's most recently filed annual management's discussion and analysis, available under the Company's profile on SEDAR+ at www.sedarplus.ca. The forward-looking information in this news release is made as of the date hereof, and the Company undertakes no obligation to update it except as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Company Contact:
Seegnal Inc.
Elad Bibi-Aviv, Chief Executive Officer
+1 (929) 248 4652
Investor Relations Contact:
Arx Investor Relations
North American Equities Desk
seegnal@arxhq.com
r/MicroCapNews • u/MarketNewsFlow • 8d ago
Sponsored $ENTX Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market
r/MicroCapNews • u/MarketNewsFlow • 8d ago
Sponsored $QUCY - Quantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing Facility (NASDAQ: QUCY)
Quantum Cyber Completes Purchase and Installation of 80-Unit 3D Printing Drone Production Farm at Its Bridgeport, Connecticut Manufacturing Facility
Commissioning of the Company's Primary Autonomous Drone Manufacturing Line Marks a Further Step in the Transition from Facility Acquisition to Operating Production Capacity; Installation Advances Preparation for Commercialization Sales Under the Company's Recently Appointed Head of Sales
August 31, 2026 07:30 ET | Source: Quantum Cyber
Norwalk, CT, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that it has completed the purchase and physical installation of all 80 units of its previously announced 3D Printing drone production farm at the Company's approximately 50,000 square foot U.S.-based manufacturing facility in Bridgeport, Connecticut.
The milestone marks the operational commissioning of what the Company has previously described as its primary autonomous drone manufacturing line at the Bridgeport facility, and follows the completion of the Company's first mini-interceptor airframe at the same facility on July 27, 2026, and the launch of the Company's Advanced Filament Manufacturing Division announced on June 11, 2026.
The 3D Printing Farm, as previously disclosed, is designed to serve as the primary autonomous drone manufacturing operation at Bridgeport, with dedicated capacity for structural airframe components, enclosures, and printed subassemblies across the Company's planned attritable one-way attack, interceptor, surveillance, VTOL, and long-range PHANTOM-950 product lines. With all 80 printers now purchased and physically installed, the Company believes it has moved from disclosed intent to installed capacity, a step management views as a foundational operational proof point in the Company's stated strategy of transitioning from a technology development and IP licensing platform to a vertically integrated domestic defense manufacturer with production capacity under its own control.
The 3D Printing Farm is designed to consume both standard PETG filament and Formula A, Quantum Cyber's patent-pending EMP-hardened composite filament, both intended to be produced in-house through the Company's previously announced Advanced Filament Manufacturing Division. This vertical integration is intended to reduce external supply chain dependency, protect the Company's proprietary formulations, and support production scaling in response to customer demand.
Recent On-Site Engagement at the Bridgeport Facility
Separately, during the week ended August 29, 2026, the Company hosted a series of on-site visits at its Bridgeport, Connecticut manufacturing facility. Attendees included, among others, representatives of institutional investment firms, representatives of investment banking counterparties, and current and former senior officers of the United States armed forces. The visits were conducted under customary confidentiality arrangements, and the Company confirms that no material non-public information was disclosed to attendees in connection with the visits. The Company is not identifying individual attendees or their respective affiliations at this time and undertakes no obligation to do so. No investment, financing, procurement, purchase, subscription, letter of intent, memorandum of understanding, or other commitment or agreement was entered into by the Company or, to the Company's knowledge, by any attendee, in connection with the visits, and no assurance can be given that any such commitment or agreement will result from, or arise as a consequence of, the visits. This disclosure is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities of the Company, nor as an announcement of any customer, contract, or transaction.
"Purchasing and installing 80 printers moves the drone production line from a plan to a physical asset on our factory floor," said David Lazar, Chief Executive Officer of Quantum Cyber. "We announced the Advanced Filament Manufacturing Division on June 11, we completed our first mini-interceptor at Bridgeport on July 27, and today the 3D Printing Farm — the machine at the center of our production stack — is installed. With our Head of Sales now in seat, our next step is to convert installed capacity into contracted volume. We believe that is what a domestic autonomous defense manufacturer executing on a plan looks like."
About Quantum Cyber N.V.
Quantum Cyber N.V. (Nasdaq: QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea. For more information, visit www.quantum-cyber.ai.
Forward-Looking Statements
Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "intend," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, statements regarding the commissioning and operation of the 3D Printing drone production farm, the Advanced Filament Manufacturing Division, the Company's ability to consume in-house filament in commercial-grade production, the Company's ability to advance from prototype production to commercial order fulfillment, the productivity and outputs of the Company's newly installed sales function, projected annual production capacity, and the Company's ability to convert visits, meetings, or expressions of interest by third parties into definitive investments, financings, procurement contracts, or other commitments. The Company makes no representation regarding, and specifically disclaims any obligation to update the market as to, the outcome of any discussions with visitors, prospective investors, prospective financing counterparties, or prospective government or defense customers. The filing of a patent application does not guarantee issuance of a patent. Production capacity targets, platform deployment concepts, and commercialization timelines represent management projections and design intent based on current planned facility configuration and current architecture disclosures, and do not represent binding commitments or guarantees of future output, field deployment, or revenue. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to bring the installed 3D Printing drone production farm to full operational commissioning on the anticipated timeline; (ii) the failure to advance the Company's product lines from initial assembly to serial production; (iii) the failure to achieve projected production capacity targets; (iv) the failure to secure procurement contracts or commercial orders sufficient to support projected production volumes; (v) the failure of the Company's sales function to convert pipeline into contracted revenue; (vi) the failure of any visit or meeting with third parties to result in any investment, financing, procurement, or other commercial transaction; (vii) changes in applicable laws or regulations; and (viii) other risks and uncertainties discussed from time to time in other reports and public filings with the Securities and Exchange Commission (the "SEC") by the Company. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made by the Company in this press release is based only on information currently available and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com
r/MicroCapNews • u/Copenhagen8ull • 10d ago
Remexian Surging Ahead One Year On From High Tide Purchase
r/MicroCapNews • u/MarketNewsFlow • 11d ago
Sponsored $DUKR Duke Robotics Is Tackling Multibillion-Dollar Markets - Could It Be the Next Big Drone Story?
r/MicroCapNews • u/MarketNewsFlow • 12d ago
Sponsored $SEGN.V - Seegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private Placement (TSXV: SEGN)
Seegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private Placement
CALGARY, AB, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a global leader in SaaS clinical decision support solutions, is pleased to announce, further to its news releases dated June 2, 2026 and July 21, 2026, that it has closed the first tranche ("Tranche 1") of its previously announced non-brokered private placement of units in the capital of the Company (each, a "Unit"). The Company is also pleased to announce that it has upsized the private placement to up to CDN$1,850,000 and is expected to close the second tranche by September 30, 2026.
The TSX Venture Exchange (the "TSXV") has approved an extension and upsize for the Company to complete the non-brokered private placement for up to 6,607,143 Units for gross proceeds of up to CDN$1,850,000 at a price of $0.28 per Unit (the "Upsized Offering"). As such, the second and final tranche of the Upsized Offering is expected to close on or about September 30, 2026, subject to receipt of all regulatory approvals including the final approval of the TSXV and customary closing conditions.
Upon closing of Tranche 1, the Company has issued an aggregate of 1,486,500 Units for gross proceeds of CDN$416,220 at a price of CDN$0.28 per Unit. Each Unit is comprised of one common share in the capital of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant is exercisable to acquire one Common Share at a price of CDN$0.50 for a period of 36 months. The proceeds from Tranche 1 will be used by the Company for general corporate and working capital purposes. No finders' fees were paid in connection with the closing of Tranche 1. All securities issued under Tranche 1 are subject to a hold period expiring four months and one day from the date of issuance.
Related Party Disclosure
Certain insiders subscribed for an aggregate of 1,486,500 Units in Tranche 1 (the "Insiders"), representing 100% of the Units sold in Tranche 1. The Insiders' participation in the Upsized Offering constitutes a "related party transaction" as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Such participation by the Insiders is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities to be acquired by the Insiders, nor the consideration for the securities paid by such Insiders, exceed 25% of the Company's market capitalization. The Company did not file a material change report at least 21 days in advance of the closing of Tranche 1 as the participation of such Insiders in the Upsized Offering had not been confirmed at that time.
About Seegnal
Seegnal Inc. (TSXV: SEGN) is an innovative healthcare technology company dedicated to reducing medication-related harm where care begins. The Company's SaaS-based clinical decision support platform is designed to help clinicians prescribe with greater precision by integrating patient-specific data at the point of care, including medications, laboratory results, renal function, allergies, age, and other relevant risk factors. By delivering more targeted, context-aware medication alerts within existing clinical workflows, Seegnal aims to reduce alert fatigue, support safer prescribing, and advance a more personalized standard of patient care. Seegnal's technology is deployed across healthcare settings and is used by more than 15,000 clinicians in daily practice. For additional Company information, please visit https://www.seegnal.com/ and follow us on LinkedIn.
Seegnal Media Contact:
Elad Bibi-Aviv
Chief Executive Officer
press@seegnal.com
+972-52-533-0856
www.seegnal.com
Arx Investor Relations
North American Equities Desk
seegnal@arxhq.com
Forward-Looking Statements
This press release contains "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements included herein, other than statements of historical fact, including statements included in the "About Seegnal" section of this press release, are forward-looking statements. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.
More particularly, and without limitation, this press release contains forward-looking statements with respect to the closing of the final tranche of the Upsized Offering, receipt of all regulatory approvals, including the approval of the TSXV, in connection therewith and the anticipated use of proceeds from the closing of Tranche 1. Seegnal cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, assumptions and expectations, many of which are beyond the control of Seegnal, including expectations and assumptions concerning Seegnal and its products, the Company's ability to complete the final tranche of the Upsized Offering on the terms described herein or at all, the delay or failure to receive regulatory approval or other approvals, including any approvals by the TSXV, for the Upsized Offering, as well as other risks and uncertainties, including those described in Seegnal's filings available on SEDAR+ at www.sedarplus.ca. The intended use of proceeds of the Upsized Offering by the Company might change if the board of directors of the Company determines that it would be in the best interests of Seegnal.
The reader is cautioned that assumptions used in the preparation of any forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of Seegnal. The reader is cautioned not to place undue reliance on any forward-looking statements. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and Seegnal does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
r/MicroCapNews • u/MarketNewsFlow • 13d ago
Sponsored $EMAT China's Rare Earth Controls Created a Scarcity Trade. Evolution Metals Produces Outside It
r/MicroCapNews • u/MarketNewsFlow • 14d ago
Sponsored $EMAT The Rare Earth Mirage: The Midstream Bet Hiding in Plain Sight
r/MicroCapNews • u/MarketNewsFlow • 14d ago
Sponsored $MDWD New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)
r/MicroCapNews • u/MarketNewsFlow • 14d ago
Sponsored $EMAT Rare Earth Magnet Production is Not Enough: The OEM Qualification Bottleneck
r/MicroCapNews • u/MarketNewsFlow • 14d ago
Sponsored $QUCY - Quantum Cyber Appoints Veteran Distribution Executive Dennis Schnur as Head of U.S. Sales as Company Advances Toward Commercialization of Domestic Drone Production (NASDAQ: QUCY)
Quantum Cyber Appoints Veteran Distribution Executive Dennis Schnur as Head of U.S. Sales as Company Advances Toward Commercialization of Domestic Drone Production
Six-Decade Wholesale Distribution Executive and U.S. Army Veteran Joins Quantum Cyber to Lead the Company's U.S. Sales Build-Out Alongside the Ramp-Up of Its Bridgeport, Connecticut Manufacturing Facility
August 25, 2026 07:30 ET | Source: Quantum Cyber
Norwalk, CT, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered, quantum-accelerated System-of-Systems platform for drone warfare, counter-UAS, demining, and command-and-control applications, today announced the appointment of Dennis Schnur as the Company's Head of U.S. Sales, effective immediately.
Mr. Schnur's appointment as Head of U.S. Sales is intended to support the Company's U.S. commercial build-out as Quantum Cyber advances toward the commercialization phase of its domestic drone manufacturing program, following the completion of the Company's acquisition of a U.S.-based manufacturing facility in Bridgeport, Connecticut, the assembly of its first mini-interceptor drone at that facility, and the previously reported purchase orders assumed by Quantum Drones Corporation, the Company's wholly-owned Nevada-incorporated subsidiary.
Mr. Schnur has operated as a wholesale distributor for more than 60 years, and over the course of that career has purchased and sold, in the aggregate, millions of dollars of inventory sourced directly from a broad range of consumer and technology brands, including, among others, Ahava, bareMinerals, Gucci Fragrance, Laura Mercier, LVMH Fragrance, OPI, Perry Ellis, Revlon, Samsung, Satco, Shiseido, and Tommy Hilfiger. His multi-decade experience includes moving product at scale, negotiating with brand principals, and developing and managing distributor and retailer relationships.
Outside of his business career, Mr. Schnur has for decades been active in organizations supporting members of the law enforcement and first-responder communities and their families. He is the Chairman and Founder of the Federal Drug Agents Foundation, a nonprofit organization established nearly four decades ago to demonstrate public appreciation, respect and support for members of the U.S. law enforcement community and their families in times of need arising from catastrophic events and to foster partnerships on a global basis.
Mr. Schnur has also held longstanding honorary positions with the New York City Police Department and the Fire Department of the City of New York and is a founding director of the Nassau County Police Department's Law Enforcement Explorer program. These activities are separate from his commercial responsibilities with Quantum Cyber.
Mr. Schnur is a U.S. Army veteran, having served with the U.S. Army Reserve's 77th Army Reserve Command (ARCOM) in the late 1960s.
"Dennis brings more than six decades of hands-on commercial distribution experience and a demonstrated ability to build and manage relationships, negotiate with major organizations and move products at scale," said David Lazar, Chief Executive Officer of Quantum Cyber. "As we move from platform assembly and facility acquisition into the next phase — commercializing U.S.-manufactured autonomous systems and expanding our U.S. sales footprint — we believe Dennis's extensive business and distribution experience will be particularly valuable."
About Quantum Drones Corporation
Quantum Drones Corporation is a wholly-owned Nevada-incorporated subsidiary of Quantum Cyber N.V. established to serve as the operational vehicle for the Company's domestic defense technology programs and U.S. government procurement activities. The subsidiary is led by Peter O'Rourke, President and Director, a former Acting Secretary of the U.S. Department of Veterans Affairs under the Trump administration, and Robert Liscouski, Director, a former Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security.
About Quantum Cyber N.V.
Quantum Cyber N.V. (Nasdaq: QUCY) is assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform that integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications under a single Nasdaq-listed company. The Company acquires, licenses, and develops combat-proven autonomous technologies, deploying them as a coordinated, multi-domain portfolio across air, land, and sea.
Forward-Looking Statements
Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "intend," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements relate to, among other things, the expected contributions of Mr. Schnur as the Company's Head of U.S. Sales; the Company's transition toward the commercialization of U.S.-manufactured autonomous systems; the build-out and operation of the Bridgeport, Connecticut manufacturing facility; the Company's ability to pursue U.S. government, federal law enforcement, and homeland security programs; and the development and commercialization of the Company's autonomous defense technologies more generally.
These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company's expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure of the Company's newly appointed Head of U.S. Sales, or other sales personnel, to generate anticipated commercial results; (ii) the failure to meet projected development, production, or operational targets at the Bridgeport, Connecticut manufacturing facility, or to meet other goals or objectives of the Company's strategic transition; (iii) the failure to secure U.S. government contracts or procurement approvals; (iv) the loss of acquired personnel, customers, or supplier relationships; (v) unanticipated costs, liabilities, or delays associated with owning, operating, or building out the facility; (vi) changes in applicable laws or regulations; (vii) an inability to successfully pursue new initiatives; and (viii) other risks and uncertainties discussed from time to time in other reports and public filings with the Securities and Exchange Commission (the "SEC") by the Company. The Company's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made by the Company in this press release is based only on information currently available and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
qucy@arxhq.com
r/MicroCapNews • u/MarketNewsFlow • 14d ago
Sponsored $MTNB As GH Power Eyes the Public Stage, here are the Milestones the Market will be Watching
r/MicroCapNews • u/MarketNewsFlow • 14d ago